Carcinoma of the endometrium and hormonal receptors

  • P. G. Satyaswaroop
  • R. J. Zaino
  • R. Mortel
Part of the Cancer Treatment and Reasearch book series (CTAR, volume 49)


Carcinoma of the endometrium is the most common gynecologic malignancy in the United States, accounting for 38,000 new cases and 3,200 deaths every year [1]. Although surgery and radiation therapy are quite effective and achieve 80–90% cure rates in early stages, most of the fatalities occur in patients with advanced, recurrent, or metastatic disease.


Nude Mouse Endometrial Carcinoma Steroid Receptor Endometrial Adenocarcinoma Nude Mouse Model 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Silverberg E, 1982. Cancer statistics. CA 32:18–42.Google Scholar
  2. 2.
    Kelley RM, Baker WH, 1960. Progestational agents in the treatment of carcinoma of the endometrium. N Engl J Med 264:216–222.CrossRefGoogle Scholar
  3. 3.
    Deppe E, 1984. Chemotherapy of endometrial carcinoma. In Chemotherapy of Gynecologic Cancer, (Deppe D, ed) New York: Alan R. Liss, pp. 139–150.Google Scholar
  4. 4.
    Jensen EU, DeSombre ER, 1972. Mechanism of action of female sex hormones. Annu Rev Biochem 41:203–230.PubMedCrossRefGoogle Scholar
  5. 5.
    Gorski J, Ganong F, 1976. Current models of steroid hormone action: A critique. Annu Rev Physiol 38:425–450.PubMedCrossRefGoogle Scholar
  6. 6.
    McGuire WL, Carbone PO, Vollmer EP, 1975. Estrogen Receptors in Human Breast Cancer. New York: Raven Press.Google Scholar
  7. 7.
    Allegra JC, Lippman ME, Thompson EB, Simon R, Bartock A, Green L, Hupp KK, Do HMI, Aitken SC, Warren R, 1978. Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer. Cancer Treat Rep 62:1281–1286.PubMedGoogle Scholar
  8. 8.
    McGuire WL, 1978. Hormones, Receptors and Breast Cancer. New York: Raven Press.Google Scholar
  9. 9.
    Mortel R, Zaino RJ, Satyaswaroop PG, 1984. Sex steroid receptors and hormonal treatment of endometrial cancer. In Chemotherapy of Gynecologic Cancer, (Deppe G, ed). New York: Alan R Liss pp. 125–138.Google Scholar
  10. 10.
    Martin PM, Rolland PH, Gammere M, Serment H, Toga M, 1979. Estradiol and progesterone receptors in normal and neoplastic endometriums: Correlations between receptors, histopathological examinations and clinical responses under progestin therapy. Int J Cancer 24:324–329.Google Scholar
  11. 11.
    Benraad TJ, Friberg LG, Koenders AJM, Kullander S, 1980. Do estrogen and progesterone receptors in metastasizing endometrial cancers predict the response to gestagen therapy? Acta Obstet Gynecol Scand 59:155–159.PubMedCrossRefGoogle Scholar
  12. 12.
    Creasman WT, McCarty KS,Sr, Barton TK, McCarty KS,Sr, 1980. Clinical correlates of estrogen and progesterone binding proteins in human endometrial adenocarcinoma. Obstet Gynecol 55:363–370.PubMedGoogle Scholar
  13. 13.
    McCarty KS,Jr, Barton TK, Fetter BF, Creasman WT, McCarty KS,Sr, 1979. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma. Am J Pathol 96:171–183.PubMedGoogle Scholar
  14. 14.
    Martin PM, 1982. Endometrial cancer: Correlations between estrogen and progestin receptor status, histopathological findings, and clinical responses during progestin therapy. Excerpta Med Int Can Series 611:333–349.Google Scholar
  15. 15.
    Mortel R, Levy C, Wolff J-P, Nicholas J-C, Robel P, Baulieu E-E, 1981. Female sex steroid receptors in postmenopausal endometrial carcinoma and biochemical response to antiestrogen. Cancer Res 41:1140–1147.PubMedGoogle Scholar
  16. 16.
    Satyaswaroop PG, Mortel R, 1982. Failure of progestins to induce estradiol dehydrogenase activity in endometrial carcinoma. Cancer Res 42:1322–1325.PubMedGoogle Scholar
  17. 17.
    Mortel R, Zaino RJ, Satyaswaroop PG, 1984. Heterogeneity and progesterone receptor distribution in endometrial adenocarcinoma. Cancer 53:113–116.PubMedCrossRefGoogle Scholar
  18. 18.
    Satyaswaroop PG, Zaino R, Mortel R, 1983. Human endometrial adenocarcinoma transplanted into nude mice: Growth regulation by estradiol. Science 219:58–60.PubMedCrossRefGoogle Scholar
  19. 19.
    Satyaswaroop PG, Zaino RJ, Mortel R, 1987. Steroid receptors and human endometrial carcinoma: Studies in a nude mouse model. Ca Metastas Rev 6:223–241.CrossRefGoogle Scholar
  20. 20.
    Clarke CL, Satyaswaroop PG, 1985. Photoaffinity labeling of the progesterone receptor from human endometrial carcinoma. Cancer Res 45:5417–5420.PubMedGoogle Scholar
  21. 21.
    Satyaswaroop PG, Zaino RJ, Mortel R, 1984. Estrogen-like effect of tamoxifen on human endometrial carcinoma transplanted into nude mice. Cancer Res 44:4006–4010.PubMedGoogle Scholar
  22. 22.
    Zaino RJ, Satyaswaroop PG, Mortel R, 1984. Morphology of human uterine cancer in nude mice. Arch Pathol Lab Med 108:571–578.PubMedGoogle Scholar
  23. 23.
    Zaino RJ, Satyaswaroop PG, Mortel R, 1985. Hormonal therapy of human endometrial carcinoma in a nude mouse model. Cancer Res 45:539–541.PubMedGoogle Scholar
  24. 24.
    Mortel R, Satyaswaroop PG, Clarke CL, Zaino R, 1986. Sex steroid receptors in normal and malignant endometrium. Ann Pathol 6:109–114.PubMedGoogle Scholar
  25. 25.
    Clarke CL, Zaino RJ, Feil PD, Miller JV, Steck ME, Ohlsson-Wilhelm BM, Satyaswaroop PG, 1987. Monoclonal antibodies to human progesterone receptor: Characterization by biochemical and immunohistochemical techniques. Endocrinology 121:1123–1132.PubMedCrossRefGoogle Scholar
  26. 26.
    Zaino RJ, Clarke CL, Mortel R, Satyaswaroop PG, 1988. Heterogeneity of progesterone receptor distribution in human endometrial adenocarcinoma. Cancer Res 48:1889–1895.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • P. G. Satyaswaroop
  • R. J. Zaino
  • R. Mortel

There are no affiliations available

Personalised recommendations